Indan Journal of Medical Research Indan Journal of Medical Research Indan Journal of Medical Research Indan Journal of Medical Research
  Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login  
  Home Print this page Email this page Small font sizeDefault font sizeIncrease font size Users Online: 2195       
REVIEW ARTICLE
Year : 2014  |  Volume : 139  |  Issue : 5  |  Page : 667-674

Progeria: A rare genetic premature ageing disorder


Endocrinology & Metabolism Division, National Institute of Nutrition (ICMR), Hyderabad, India

Correspondence Address:
Dr Manchala Raghunath
Scientist 'F', Endocrinology & Metabolism Division, National Institute of Nutrition (ICMR), Tarnaka, Hyderabad 500 007
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


PMID: 25027075

Rights and PermissionsRights and Permissions

Progeria is characterized by clinical features that mimic premature ageing. Although the mutation responsible for this syndrome has been deciphered, the mechanism of its action remains elusive. Progeria research has gained momentum particularly in the last two decades because of the possibility of revealing evidences about the ageing process in normal and other pathophysiological conditions. Various experimental models, both in vivo and in vitro, have been developed in an effort to understand the cellular and molecular basis of a number of clinically heterogeneous rare genetic disorders that come under the umbrella of progeroid syndromes (PSs). As per the latest clinical trial reports, Lonafarnib, a farnesyltranferase inhibitor, is a potent 'drug of hope' for Hutchinson-Gilford progeria syndrome (HGPS) and has been successful in facilitating weight gain and improving cardiovascular and skeletal pathologies in progeroid children. This can be considered as the dawn of a new era in progeria research and thus, an apt time to review the research developments in this area highlighting the molecular aspects, experimental models, promising drugs in trial and their implications to gain a better understanding of PSs.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed3602    
    Printed37    
    Emailed1    
    PDF Downloaded968    
    Comments [Add]    

Recommend this journal